SY
Putnam BioRevolution ETF
SYNB · AMEX
$31.61 -0.37% (-$0.12)
Market Cap ¥37.4M
P/E Ratio -159.26x
Div. Yield 0.68%
ROE -
Valuation
65 /100
Fair P/E -159.26x
P/S 0.02x
P/B 0.01x
Growth
55 /100
Stable EPS growth 9.23%
Rev. growth 17.83%
Book val. growth 4.57%
Profitability
0 /100
Weak Net margin 90.07%
Op. margin 119.05%
Gross margin N/A
Quality
30 /100
Poor ROA 15.38%
Asset turnover 0.17x
ROIC N/A
Debt
100 /100
Low Current ratio 1.23x
Debt/Equity N/A
Int. coverage N/A
Stability
70 /100
Stable Beta 1.07x
Rev. volatility 69.90%
Profitable years 6
Bulios Scoring descrie calitatea și istoricul unei companii, nu randamentul viitor. Un scor ridicat nu este un semnal de cumpărare. Află mai multe
Întreabă StockBot despre SYNB
Online
Sector
Financial Services
Industry
Asset Management
CEO
-
Employees
-
Headquarters
San Mateo